No Detail Found!

Development, characterization and optimization of methotrexate-olive oil nano-emulsion for topical application

Author(s)
Sheikh Abdur Rashid College of Pharmacy, University of Sargodha,Sargodha,Pakistan; Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Sajid Bashir College of Pharmacy, University of Sargodha,Sargodha,Pakistan
Hashmat Ullah Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Kifayat ullah Shah Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Daulat Haleem Khan Department of Pharmacy, Lahore College of Pharmaceutical Sciences,Lahore,Pakistan
Pervaiz Akhtar Shah Punjab University College of Pharmacy, University of Punjab,Lahore,Pakistan
Muhammad Zeeshan Danish Punjab University College of Pharmacy, University of Punjab,Lahore,Pakistan
Muhammad Hashim Khan Gomal Center of Biochemistry and Biotechnology, Gomal University D.I.,Khan,Pakistan
Saima Mahmood Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Muhammad Sohaib Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Malik Muhammad Irfan Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Adnan Amin. Faculty of Pharmacy Gomal University D.I.,Khan,Pakistan
Abstract
The chronic inflammatory conditions like psoriasis has an increased prevalence and is linked with various associated life threatening disease conditions. The main objective of this project was to developed a methotrexate-olive loaded nano emulsion. The formulation was assessed for various parameters including Thermodynamic Stability, physico-chemically characterization, drug release kinetics and entrapment efficiency and in vitro/ in vivo skin permeation analysis. Final optimized formulation had a particle size 18.27±5.78 nm with a PDI of 0.25±0.01, whereas the average entrapment efficiency of formulation was 74.68±2.1%. The release kinetics suggested 97.72% drug release at pH 5 after 20 hrs. The FTIR data confirmed that the chemical structure of drug is retained with efficient loading into the formulation. Permeation data showed that an average of 79.23±3.6µg/cm2 of methotrexate was permeated from the nano emulsion with an average flux of 2.326±0.45µg/cm2/h after 24 hrs. Finally in vivo studies on rabbit skin confirmed that the structural changes of intercellular lipid layers in the stratum corneum are not responsible for enhanced skin permeation of methotrexate loaded nano emulsion. It was concluded that olive oil based MTX-NE is suitable for topical application and can be used for management of psoriasis.
Publication Details
Page(s) 205-215
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
skin permeation, topical delivery, Psoriasis, in vivo analysis, Psoriasis
References
Agnihotri SA,Jawalkar SS,Aminabhavi TM .2006 .Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size and drug release. Eur. J. Pharm. Biopharm., 63(3) : 249-261.
Ali MS,Alam MS,Alam M,Siddiqui MR .2014 .Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran. J. Pharm. Res., 13(4) : 1125-1140.
Bali V,Ali M,Ali J .2011 .Nanocarrier for the enhanced bioavailability of a cardiovascular agent: In vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int. J. Pharm., 403(1-2) : 46-56.
Chandran V,Raychaudhuri SP,Chong HT,Kopecki Z,Cowin AJ .2013 .Lifting the silver flakes: The pathogenesis and management of chronic plaque psoriasis. BioMed. Res. Inter, 168321(3) : J314.
Czajkowska-Kossnik A,Szekalska M,Amelian A,Szymańska E,Winnicka K .2015 .Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin. Molecules, 20(12) : 21010-21022.
Divya G,Panonnummal R,Gupta S,Jayakumar R,Sabitha M .2016 .Acitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasis. Eur. J. Pharm. Biopharm., 107 : 97-109.
Gupta M,Agrawal U,Vyas SP U .2012 .Nanocarrierbased topical drug delivery for the treatment of skin diseases. Expert Opin. Drug Deliv, 9(7) : 783-804.
Ioele G,Tavano L,De Luca M,Ragno G,Picci N,Muzzalupo R .2015 .Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations. Int J. Pharm., 494(1) : 490-497.
Kreilgaard M .2002 .Influence of microemulsions on cutaneous drug delivery. Adv. Drug. Deliv. Rev., 54(Suppl) : S77-S98.
Lawrence MJ,Rees GD .2000 .Microemulsionbased media as novel drug delivery systems. Adv. Drug. Deliv. Rev., 45(1) : 89-121.
Laws PM,Young HS .2012 .Current and emerging systemic treatment strategies for psoriasis. Drugs, 72(14) : 1867-80.
Liu D,Ge Y,Tang Y,Yuan Y,Zhang Q,Li R,Xu Q .2010 .Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: Preparation, characterization and in vitro studies. J, 27(8) : 726-734.
Lopes LB .2014 .Overcoming the cutaneous barrier with microemulsions. Pharmaceutics, 6(1) : 52-77.
López A,Llinares F,Cortell C,Herráez M C .2000 .Comparative enhancer effects of Span®20 with Tween®20 and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicities. Int. J. Pharm., 202(1-2) : 133-140.
Mahdi ES,Noor AM,Sakeena MH,Abdullah GZ,Abdulkarim MF,Sattar MA .2011 .Formulation and in vitro release evaluation of newly synthesized palm kernel oil esters-based nanoemulsion delivery system for 30% ethanolic dried extract derived from local Phyllanthus urinaria for skin antiaging. Int. J. Nanomedi., 6 : 2499-512.
Micha R,Imamura F,WylerVon Ballmoos M,Solomon DH,Hernán MA,Ridker PM,Mozaffarian D. .2011 .Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Americ. J. Cardiol., 108(9) : 1362-70.
Montaudie H,Sbidian E,Paul C,Maza A,Gallini A,Aractingi S,Aubin F,Misery L,Ortonne JP .2011 .Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J. Europ. Acad. Dermatol.Venereol., Suppl, 2 : 12-18.
Nawaz A,Wong TW .2017 .Microwave as skin permeation enhancer for transdermal drug delivery of chitosan-5-fluorouracil nanoparticles. Carbohydrate Polymer, 57(10) : 906-919.
Nawaz A,Wong TW .2018 .Chitosancarboxymethyl-5-fluorouracil-folate conjugate particles: Microwave modulated uptake by skin and melanoma cells. J. Invest. Dermatol, 138(11) : 2412-2422.
Ngan CL,Basri M,Tripathy M,Karjiban RA,Abdulmalek E .2014 .Physicochemical characterization and thermodynamic studies of nanoemulsion-based transdermal delivery system for fullerene. , : 219035.
Obata Y,Utsumi S,Watanabe H,Suda M,Tokudome Y,Otsuka M,Takayama K M .2010 .Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. Int. J. Pharm., 389(1-2) : 18-23.
Panonnummal R,Jayakumar R,Sabitha M .2017 .Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream. Europ. J. Pharm. Sci., 1(96) : 193-206.
Panonnummal R and Sabitha M .2018 .Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model. Int. J. Biol. Macromol, 110 : 245-258.
Papakostas D,Rancan F,Sterry W,Blume-Peytavi U,Vogt A .2011 .Nanoparticles in dermatology. , : .
Dermatol. Res. . .. , 303(8) : 533-550.
Pinto MF,Moura CC,Nunes C,Segundo MA,Costa Lima SA,Reis S SA .2014 .A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers. Int. J. Pharm., 477(1-2) : 519-526.
Rahman M,Alam K,Ahmad MZ,Gupta G,Afzal M,Akhter S,Kazmi I,Ahmad FJ,Anwar F FJ .2012 .Classical to current approach for treatment of psoriasis: A review: Endocrine, metabolic & immune disorders. Drug Target, 12(3) : 287-302.
Sabitha M,Sanoj Rejinold N,Nair A,Lakshmanan VK,Nair SV,Jayakumar R .2013 .Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydr. Polym, 91(1) : 48-57.
Saraceno R,Chiricozzi A,Gabellini M,Chimenti S M .2013 .Emerging applications of nanomedicine in dermatology. Skin. Res. Technol., 19(1) : e13-9.
Shen S,O'Brien T,Yap LM,Prince HM,McCormack CJ,Dermatol Austr. J. .2012 .The use of methotrexate in dermatology: A review',. , 53(1) : 1-18.
Sobhani H,Tarighi P,Ostad SN,Shafaati A,NafissiVarcheh N,Aboofazeli R .2015 .Formulation development and toxicity assessment of triacetin mediated nanoemulsions as novel delivery systems for rapamycin. Iran. J.Pharm. Res., 14(Suppl) : 3-21.
Sood A,Granick MS,Tomaselli NL .2014 .Wound dressings and comparative effectiveness data. Advanc. Wound Care, 3(8) : 511-529.
Vaddi HK,Chan PC,Chan YW,SY YW .2002 .Terpenes in ethanol: Haloperidol permeation and partition through human skin and stratum corneum changes. J. Control. Release, 81(1-2) : 121-33.
Li X Yin C .2011 .Anomalous diffusion of drug release from a slab matrix: Fractional diffusion models. Int. J. Pharm., 418(1) : 78-87.
Zeb A,Qureshi OS,Akram CH,Kim M,Kim HS,Kang M S,Majid JH,Chang A,Bae SY,Kim ON,JK ON .2017 .Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int. J. Pharm., 525(1) : 92-100.
Mühlen Zur,Mehnert A,W A .1998 .Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie, 45(2) : 149-55.
0

Citations

0

Downloads

8

Views